Shirley V. Wang, PhD, ScM
Brigham & Women’s Hospital
Department of Medicine
Division of Pharmacoepidemiology & Pharmacoeconomics
1620 Tremont Street, Suite 3030,
Boston, MA 02120
Phone: 617-525-8376 | Fax: 617-232-8602
Shirley Wang PhD, ScM is an Assistant Professor of Medicine at Harvard Medical School and Associate Epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital.
Her work has ranged from applied epidemiologic studies to address current clinical questions, to simulation studies evaluating methodological issues, to creation of semi-automated modular queries for rapid, sequential, safety monitoring of newly marketed medications within the FDA’s Mini-Sentinel framework. Her particular research interest is in development of non-traditional analytic methods. The foci of Dr. Wang’s methodological work have been in the areas of self-controlled designs, semi-automated active surveillance methods, as well as methods for prediction of individual level heterogeneity of treatment effects.
Dr. Wang received her doctorate in epidemiology and masters in biostatistics from Brown University and was awarded both the Reuel A. Stallones student prize paper from the Society for Epidemiologic Research and the Stanley A. Edlavitch best abstract award from the International Conference on Pharmacoepidemiology & Therapeutic Risk Management in 2011.
Selected Publications Current PubMed Search Results
Wang SV, Verpillat P, Rassen JA, Patrick A, Garry EM, Bartels DB. Transparency and reproducibility of published observational cohort studies. Clin Pharmacol Ther. 2015 Dec 21. doi: 10.1002/cpt.329. PMID: 26690726.
Wang SV, Schneeweiss S, Maclure M, Gagne JJ. “First-wave” bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs. Am J Epidemiol 2014 Aug 1. doi: 10.1093/aje/kwu162. PMID: 25086050.
Wang SV, Gagne JJ, Glynn RJ, Schneeweiss S. Case-crossover Studies of Therapeutics: Design Approaches to Addressing Time-varying Prognosis in Elderly Populations . Epidemiology. 2013 Mar 5. [Epub ahead of print] PubMed PMID: 23466528.
Wang S, Linkletter C, Dore D, Mor V, Buka S, Maclure M. Age, antipsychotics, and the risk of ischemic stroke in the Veterans Health Administration . Stroke. 2012 Jan;43(1):28-31. doi: 10.1161/STROKEAHA.111.617191. Epub 2011 Oct 27. PubMed PMID: 22033997.
Wang S, Linkletter C, Maclure M, Dore D, Mor V, Buka S, Wellenius GA. Future cases as present controls to adjust for exposure trend bias in case-only studies . Epidemiology. 2011 Jul;22(4):568-74. doi: 10.1097/EDE.0b013e31821d09cd. PubMed PMID: 21577117; PubMed Central PMCID: PMC3110688.
Wang SV, Coull BA, Schwartz J, Mittleman MA, Wellenius GA. Potential for bias in case-crossover studies with shared exposures analyzed using SAS . Am J Epidemiol. 2011 Jul 1;174(1):118-24. doi: 10.1093/aje/kwr038. Epub 2011 May 3. PubMed PMID: 21540322; PubMed Central PMCID: PMC3133813.